I read with interest the article in Angiology that determined the role of anxiety level in radial artery spasm during transradial coronary angiography. 1 As the importance of conducting more randomized-controlled trials using anxiolytics to define the relation between anxiety and vasospasm was noted by the authors, I offer the following insights for investigators to consider when conducting such research. Although previous research has already identified that moderate procedural sedation and opioid analgesia reduces the incidence of vasospasm, 2 the identification of risk factors in the present study is hypothesis generating as to how outcomes might be even further improved. It is possible that selectively applying either even more intensive sedation and analgesia or complementary nonpharmacological stressreducing therapies, such as music therapy or visualization and attentive behavior, to patients ''at-risk'' of vasospasm (women and those with high levels of anxiety prior to the procedure) might lead to even better patient outcomes. 3, 4 Also of note, the only randomized controlled trial of sedation to reduce vasospasm during transradial cardiac catheterization that has been conducted was not placebo controlled. 2 Future similar trials should consider incorporating a placebo-controlled arm so that we can be more confident that any reduction in vasospasm is due to the administration of the specific combination of sedative and analgesic medications used as opposed to the placebo effect of receiving any treatment at all. Moreover, in the previous trial of sedation during transradial coronary procedures, a standardized dose of medication was used.
2 As the hypothesis being tested is that reduction in the pain and anxiety associated with undergoing a cardiac procedure will reduce sympathetic tone and in turn reduce the incidence of vasospasm, titrating sedative and analgesic medications according to patient response would be more appropriate than standardized dosing. Yet, in order to incorporate this approach to the controlled-trial context, a standardized and validated approach would be required to measure pain and anxiety during the procedures. Sedation scales have been used frequently in the intensive care setting to evaluate the effectiveness of different sedative and analgesic medications in randomized controlled trials. 5, 6 Application of these scales for use in randomized controlled trials of sedative and analgesic regimens in the cardiac catheterization laboratory setting should therefore be explored. However, none of these scales have been specifically validated for use in the cardiac catheterization context. 7 Thus, further research in this area would be beneficial in order to strengthen the methodological quality of future randomized controlled trials that are focused on determining whether sedation and analgesia can improve outcomes for patients undergoing transradial cardiac catheterization.
